Your browser doesn't support javascript.
loading
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19.
Zelek, Wioleta M; Cole, Jade; Ponsford, Mark J; Harrison, Richard A; Schroeder, Ben E; Webb, Nicholas; Jolles, Stephen; Fegan, Christopher; Morgan, Matt; Wise, Matt P; Morgan, B Paul.
Affiliation
  • Zelek WM; Cardiff University, Cardiff, United Kingdom.
  • Cole J; University Hospital of Wales, Cardiff, United Kingdom and.
  • Ponsford MJ; Cardiff University, Cardiff, United Kingdom.
  • Harrison RA; University Hospital of Wales, Cardiff, United Kingdom and.
  • Schroeder BE; Cardiff University, Cardiff, United Kingdom.
  • Webb N; University Hospital of Wales, Cardiff, United Kingdom and.
  • Jolles S; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Fegan C; University Hospital of Wales, Cardiff, United Kingdom and.
  • Morgan M; Cardiff University, Cardiff, United Kingdom.
  • Wise MP; Cardiff University, Cardiff, United Kingdom.
  • Morgan BP; University Hospital of Wales, Cardiff, United Kingdom and.
Am J Respir Crit Care Med ; 202(9): 1304-1308, 2020 11 01.
Article in En | MEDLINE | ID: mdl-32897730

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Complement Inactivator Proteins / Coronavirus Infections / Betacoronavirus Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Complement Inactivator Proteins / Coronavirus Infections / Betacoronavirus Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: United States